Candidate inhibitors of porcine complement

This publication has 46 references indexed in Scilit:

• Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop
  Molecular Immunology, 2006
• Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation
  Proceedings of the National Academy of Sciences, 2006
• Effects of Nafamostat Mesilate on ADP-Induced Platelet Aggregation and Disaggregation in Hemodialysis Patients
  Asaio Journal, 2006
• Humanized Recombinant Vaccinia Virus Complement Control Protein (hrVCP) with Three Amino Acid Changes, H98Y, E102K, and E120K Creating an Additional Putative Heparin Binding Site, Is 100‐fold More Active Than rVCP in Blocking Both Classical and Alternative Complement Pathways
  Annals of the New York Academy of Sciences, 2005
• Vaccinia Virus Complement Control Protein Ameliorates Collagen-Induced Arthritic Mice
  Annals of the New York Academy of Sciences, 2005
• Vaccinia Virus Complement Control Protein Diminishes Formation of Atherosclerotic Lesions: Complement Is Centrally Involved in Atherosclerotic Disease
  Annals of the New York Academy of Sciences, 2005
• Vaccinia virus complement control protein inhibits hyperacute xenorejection in a guinea pig-to-rat heterotopic cervical cardiac xenograft model by blocking both xenoantibody binding and complement pathway activation
  Transplant Immunology, 2003
• RETRACTED: Crystal Structure of a Complement Control Protein that Regulates Both Pathways of Complement Activation and Binds Heparan Sulfate Proteoglycans
  Cell, 2001
• Effects of anti‐C5a monoclonal antibodies on oxygen use in a porcine model of severe sgifis
  European Journal of Clinical Investigation, 1998
• Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC)
  Clinical and Experimental Immunology, 1993